Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease
Mark A. Oyama(University of Pennsylvania), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Gerhard Wess(University of Veterinary Medicine), Rebecca L. Stepien(University of Wisconsin–Madison), Philip R. Fox(The Schwarzman Animal Medical Center), Sonya G. Gordon(Texas A&M University), David J. Connolly, Stephen J. Ettinger, John E. Rush(Tufts University), D. David Sisson(University of Illinois Urbana-Champaign), Adrian Boswood(University of London)
Cited by 59
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|Survey of Anesthesiology|2000|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k